In addition, the downregulation or chemical inhibition of both receptors (ER-α and HER2) in the triple-positive BC cell line (BT-474) resulted in the upregulation of CBP level (Fig. 3g, h, Additional file 1: Fig. S2f, g). This evidence concerns the gene ERBB2 and breast cancer.